Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients

Wonyoung CHOI; Yun-Hee KIM; Sang-Myung WOO; Yebeen YU; Mi-Rim LEE; Woo-Jin LEE; Jung-Won CHUN; Sung-Hoon SIM; Heejung CHAE; Hyoeun SHIM; Keun-Seok LEE; Sun-Young KONG.
Cancer Research and Treatment ; : 1077-1086, 2023.
Artículo en Inglés | WPRIM | ID: wpr-999808

Documentos relacionados

  1. Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients.
  2. Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer Organoids.
  3. Human assembloids.
  4. Exploring Tumor-Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients.
  5. Bioreactor Technologies for Enhanced Organoid Culture.
  6. Microfluidic organoids-on-a-chip: The future of human models.
  7. Trellis tree-based analysis reveals stromal regulation of patient-derived organoid drug responses.
  8. Organoid screening reveals epigenetic vulnerabilities in human colorectal cancer.
  9. PDCM Finder: an open global research platform for patient-derived cancer models.
  10. Systematic evaluation of colorectal cancer organoid system by single-cell RNA-Seq analysis.